Average Co-Inventor Count = 11.98
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (10 from 175 patents)
2. Symphony Evolution, Inc. (4 from 10 patents)
14 patents:
1. 11597699 - MEK inhibitors and methods of their use
2. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
3. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors
4. 9359332 - Processes for the preparation of substituted quinazolines
5. 8697737 - Raf modulators and methods of use
6. 8658654 - Receptor-type kinase modulators and methods of use
7. 8372851 - Pyrazolo pyrimidines as casein kinase II (CK2) modulators
8. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
9. 8076338 - Kinase modulators and methods of use
10. 8012956 - Tropane compounds
11. 7915250 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
12. 7872014 - Anaplastic lymphoma kinase modulators and methods of use
13. 7846959 - Raf modulators and methods of use
14. 7803839 - Azetidines as MEK inhibitors for the treatment of proliferative diseases